Skip to main content
Figure 4 | Critical Care

Figure 4

From: Circulating soluble urokinase plasminogen activator receptor is stably elevated during the first week of treatment in the intensive care unit and predicts mortality in critically ill patients

Figure 4

Prediction of ICU mortality by sequential suPAR serum concentrations. (A) Patients that die during the course of ICU treatment had significantly higher serum suPAR levels on admittance to ICU (P = 0.005), on Day 3 (P = 0.001) and Day 7 (P = 0.014) than survivors. (B and C) Kaplan-Meier survival curves of ICU patients are displayed, showing that patients with suPAR levels of upper quartile (on admission >15 ng/mL, on Day 3 > 15 ng/mL; black) had an increased short-term mortality at the ICU as compared to patients with suPAR serum concentrations of lower quartile (on admission < 6 ng/ml, on Day 3 < 7 ng/ml; grey) or middle 50% (dotted line). P-values are given in the figure. (D and E) Kaplan-Meier survival curves of ICU patients are displayed, showing that patients with high suPAR levels (on admission > 8 ng/mL, on Day 3 > 13 ng/mL; grey) had an increased short-term mortality at the ICU as compared to patients with low suPAR serum concentrations. P-values are given in the figure.

Back to article page

Critical Care

ISSN: 1364-8535